Your search returned 45 studies. (Get alerts for new studies):
- G-CSF PMRD: Granulocyte Colony Stimulating Factor (G-CSF) Stimulated Bone Marrow and In Vivo T-Cell Depletion in Patients With Hematologic Malignancie
Conditions: Hematologic Malignancies
1 Location available
- Phase I/II Study of B Cell Malignancies Using T Cells Expressing an Anti-CD19 Chimeric Receptor: Assessment of the Impact of Lymphocyte Depletion Prio
Conditions: Chronic Lymphocytic Leukemia - Small Lymphocytic Lymphoma - Mantle Cell Lymphoma - Follicular Lymphoma - Large Cell Lymphoma
1 Location available
- Mismatched Transplantation Using High-dose Post-transplant Cyclophosphamide
Conditions: Blood Stem Cell Transplant Failure - Leukemia - Hematologic Malignancies
1 Location available
- Infusion of Off-the-Shelf Expanded Cord Blood Cells to Augment Cord Blood Transplant in Patients With Hematologic Malignancies
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Adult Acute Myeloid Leukemia in Remission - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid Leukemia With Del(5q) - Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) - Adu
1 Location available
- A Study of TAK-441 in Adult Patients With Advanced Nonhematologic Malignancies
Conditions: Advanced Nonhematologic Malignancies - Carcinoma, Basal Cell
2 Locations available
- Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies
Conditions: Malignancy - Cancer - Non Small Cell Lung Cancer - Small Cell Lung Cancer - Testicular Cancer - Thymoma - Ovarian Cancer - Osteosarcoma
4 Locations available
- A Trial of Extracorporeal Photopheresis, Pentostatin, and Total Body Irradiation in Patients Undergoing Reduced Intensity Allogeneic Stem Cell Transpl
Conditions: Hematologic Malignancies
3 Locations available
- A Phase 1b Study of MDX-1106 in Subjects With Advanced or Recurrent Malignancies
Conditions: Metastatic Castration-resistant Prostrate Cancer (mCRPC) - Renal Cell Carcinoma (RCC) - Metastatic Melanoma (MEL) - Non-small Cell Lung Cancer (NSCLC)
10 Locations available
- Reduced Intensity Stem Cell Transplantation (RIST) for Patients With Hematological Malignancies Conditioned With Fludarabine and Busulfan
Conditions: Hematologic Malignancies
1 Location available
- Trial of Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase (MEK) Inhibitor
Conditions: Acute Myeloid Leukemia - Hematological Malignancies
3 Locations available
- Perfusion CT as a Predictor of Treatment Response in Patients With Hepatic Malignancies
Conditions: Neuroendocrine Tumors - Brain (Nervous System) Cancers - Colon/Rectal Cancer - Colon Cancer - Hepatobiliary Cancers - Hepatocellular Carcinoma (Hepatoma) - Liver
1 Location available
- Genetic Study of Patients With Inherited Urologic Malignancies
Conditions: Birt Hogg Dube Syndrome - Hereditary Papillary Renal Cell Carcinoma - Kidney Cancer - Multiple Endocrine Neoplasia - Von Hippel-Lindau Syndrome
1 Location available
- Bortezomib and Reduced Intensity Allogenic Stem Cell Transplantation for Lymphoid Malignancies
Conditions: Lymphoma
1 Location available
- Non-Myeloablative Allogeneic HSCT From HLA Matched Related or Unrelated Donors for the Treatment of Low Grade B Cell Malignancies
Conditions: Multiple Myeloma - Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma - Non Hodgkin's Lymphoma - Waldenstroms - Mantle Cell Lymphoma
1 Location available
- Chemotherapy Followed by Allogeneic Stem Cell Transplantation for Hematologic Malignancies
Conditions: Hematologic Malignancies
1 Location available
- ABT-348 as Monotherapy and in Combination With Azacitidine to Treat Advanced Hematologic Malignancies
Conditions: Acute Myelogenous Leukemia - Acute Lymphoblastic Leukemia - Chronic Myelogenous Leukemia - B-cell Chronic Lymphocytic Leukemia - Myelodysplasia
3 Locations available
- Adult Double Cord Blood Transplant Study
Conditions: Cord Blood Stem Cell Transplantation - Hematologic Malignancies
11 Locations available
- Pilot Study of Expanded, Donor Natural Killer Cell Infusions for Refractory Non-B Lineage Hematologic Malignancies and Solid Tumors
Conditions: Leukemia, Myeloid, Acute - Leukemia, Lymphocytic, Acute, T-Cell - Juvenile Myelomonocytic Leukemia Lymphoblastic - T-cell Lymphoblastic Lymphoma - Myelodysplastic Syndrome
1 Location available
- Pilot Study of Haploidentical Natural Killer Cell Infusions for Poor Prognosis Non-AML Hematologic Malignancies
Conditions: Acute Lymphoblastic Leukemia - Chronic Myelogenous Leukemia - Juvenile Myelomonocytic Leukemia - Myelodysplastic Syndrome - Non-Hodgkin's Lymphoma
1 Location available
- Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies
Conditions: Stem Cell Transplantation - Leukemia - Lymphoma
1 Location available
- Busulfan-fludarabine Conditioning and T-cell Depleted Allogeneic Stem Cell Transplantation for Patients With Advanced Hematologic Malignancies
Conditions: Leukemia - Lymphoma - Myeloma
1 Location available
- Administration of Anti-CD19-chimeric-antigen-receptor-transduced T Cells From the Original Transplant Donor to Patients With Recurrent or Persistent B
Conditions: B Cell Malignancies
1 Location available
- Penostatin, Rituximab and Ontak and Allogeneic Natural Killer (NK) Cells for Refractory Lymphoid Malignancies
Conditions: Relapsed Lymphoma - B Cell Non-Hodgkin Lymphoma - Refractory Lymphoma - High Risk Chronic Lymphocytic Leukemia
1 Location available
- Vorinostat With Gemcitabine, Busulfan, and Melphalan With Stem Cell Transplant (SCT) in Relapsed or Refractory Lymphoid Malignancies
Conditions: Lymphoma
1 Location available
- Phase I Trial of Anti-CD74 (hLL1) Antibody Therapy in B Cell Malignancies
Conditions: Non-Hodgkin's Lymphoma - Chronic Lymphocytic Leukemia
1 Location available
- Study of Reduced Intensity Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT) to Treat Hematologic Malignancies and Hematopoietic Failure S
Conditions: Hematologic Neoplasms - Multiple Myeloma - Anemia, Aplastic - Hemoglobinuria, Paroxysmal - Myelofibrosis
1 Location available
- Study of Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation
Conditions: Hematologic Malignancies - Nonmalignant Diseases - Immunodeficiencies - Hemoglobinopathies - Genetic Inborn Errors of Metabolism - Fanconi's Anemia, - Thalassemia - Sickle Cell Disease
1 Location available
- Bulk Versus Fractionated Stem Cell Infusions in Patients With Hematologic Malignancies Undergoing Stem Cell Transplantation
Conditions: Leukemia
1 Location available
- Myeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric Malignancies
Conditions: Leukemia, Myelogenous, Chronic - Leukemia, Lymphoblastic, Acute - Leukemia, Myelogenous, Acute - Myeloproliferative-Myelodysplastic Diseases - Lymphoma, Malignant
1 Location available
- A Phase I Study of WT1 Peptides to Induce Anti-Leukemia Immune Responses Following Autologous or Allogeneic Transplantation for AML, CML, ALL, MDS, an
Conditions: Acute Myelogenous Leukemia (AML) - Chronic Myelogenous Leukemia (CML) - Acute Lymphoblastic Leukemia (ALL) - Myelodysplastic Syndrome (MDS) - B Cell Malignancies
1 Location available
- Bendamustine Hydrochloride, Rituximab, Etoposide, and Carboplatin in Treating Patients With Relapsed or Refractory Lymphoid Malignancies and Select Un
Conditions: Adult Grade III Lymphomatoid Granulomatosis - Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - Chronic Lymphocytic Leukemia - Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma - Con
1 Location available
- Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transpl
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome - Acute Myeloid Leukemia/Transient Myeloproliferative Disorder - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormali
5 Locations available
- A Phase 1/2 Study of the Oral ALK/EGFR Inhibitor AP26113
Conditions: Advanced Malignancies - Carcinoma, Non-Small-Cell Lung - Anaplastic Large Cell Lymphoma - Diffuse Large Cell Lymphoma - Inflammatory Myofibroblastic Tumors
6 Locations available
- CD19-specific Donor T Cells for B Cell Malignancies After Allogeneic Transplant
Conditions: Recurrent Adult Acute Lymphoblastic Leukemia - Recurrent Adult Diffuse Large Cell Lymphoma - Recurrent Grade 1 Follicular Lymphoma - Recurrent Grade 2 Follicular Lymphoma - Recurrent Mantle Cell Lymphoma - Recurrent Marginal Zone Lymphoma - Recurrent Smal
1 Location available
- Immunoablative Mini Transplant (Hematopoietic Peripheral Blood Stem Cell Transplant [HPBSC])
Conditions: Tumors - Malignant Melanoma - Hematological Malignancies - Myelogenous Leukemia, Chronic - Leukemia, Lymphoblastic, Acute
1 Location available
- A Study of MGCD265 Given With Erlotinib or Docetaxel in Subjects With Advanced Malignancies or Non-Small Cell Lung Cancer
Conditions: Advanced Malignancies, Non-small Cell Lung Cancer
2 Locations available
- Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
Conditions: Acute Undifferentiated Leukemia - Adult Acute Lymphoblastic Leukemia in Remission - Adult Acute Megakaryoblastic Leukemia (M7) - Adult Acute Myeloid Leukemia in Remission - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid
1 Location available
- A Comprehensive Study to Isolate Tumor-initiating Cells From Human Epithelial Malignancies
Conditions: Bladder Cancer - Skin Cancers - Bladder (Urothelial, Transitional Cell) Cancer - Bladder (Urothelial, Transitional Cell) Cancer Resectable (Pre-Cystectomy)
1 Location available
- Feasibility Study of a 60 Minute Rapid Infusion Rituximab Protocol in Patients With B-cell Malignancies
Conditions: Indolent or Intermediate Grade B-cell Malignancy
1 Location available
- A Clinical Study Using MEDI-551 in Adult Subjects With Relapsed or Refractory Advanced B-Cell Malignancies
Conditions: B-cell Malignancies
6 Locations available
- MLN8237 in Adults With Nonhematological Malignancies, Followed by MLN8237 in Lung, Breast, Head and Neck or Gastroesophageal Malignancies
Conditions: Advanced Nonhematological Malignancies - Non-Small Cell Lung Cancer - Small Cell Lung Cancer - Metastatic Breast Cancer - Head and Neck Squamous Cell Carcinoma - Gastroesophageal Adenocarcinoma
3 Locations available
- Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
Conditions: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome - Adult Acute Lymphoblastic Leukemia in Remission - Adult Acute Megakaryoblastic Leukemia (M7) - Adult Acute Minimally Differentiated Myeloid Leukemia (M0) - Adult Acute
1 Location available
- Study of an Investigational Drug, ASP3026, in Patients With Advanced Malignancies (Solid Tumors and B-Cell Lymphoma)
Conditions: Advanced Malignancies - B-Cell Lymphoma - Solid Tumor
2 Locations available
- Study of BMN 673, a PARP Inhibitor, in Patients With Advanced Hematological Malignancies
Conditions: Acute Myeloid Leukemia - Myelodysplastic Syndrome - Chronic Lymphocytic Leukemia - Mantle Cell Lymphoma
1 Location available
- A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers
Conditions: CD27 Expressing B-cell Malignancies - CD27 Expressing Solid Tumors - Chronic Lymphocytic Leukemia - Burkett's Lymphoma - Mantle Cell Lymphoma - Primary Lymphoma of the Central Nervous System - Marginal Zone B Cell Lymphoma - Solid Tumor - Metastatic Melan
5 Locations available
|